Welcome to our dedicated page for Cushman & Wakefield SEC filings (Ticker: CWK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cushman & Wakefield Ltd. filings document the regulatory record of a Bermuda-based commercial real estate services company listed under CWK. Its 8-K reports cover quarterly and annual financial results, Regulation FD presentations, changes in financial presentation, and capital-structure actions involving senior secured notes issued through a wholly owned subsidiary.
The company’s proxy materials disclose board matters, executive compensation, shareholder voting items, and governance practices. Other filings record corporate-status matters involving the former Cushman & Wakefield plc and related subsidiary reporting obligations, while the current registrant continues to report as Cushman & Wakefield Ltd.
Cushman & Wakefield Ltd. officer Nathaniel Robinson reported an open-market sale of Common Shares. On June 4, 2026, he sold 24,828 Common Shares at $13.25 per share. After this transaction, he directly holds 70,876 Common Shares, indicating he retains a substantial equity stake in the company.
CWK reported a Rule 144 notice covering planned and recent dispositions of Common Stock. The excerpt lists two restricted stock vesting entries of 14,780 and 10,048 shares on 02/25/2026 and 02/27/2026, and a recorded sale of 10,000 shares by Nathanial Robinson on 05/12/2026 for $135,233.75. The filing header shows a broker record with 328,971.00 (unit label in excerpt) and an effective date of 06/04/2026.
BlackRock, Inc. reports beneficial ownership of 27,719,552 shares of Cushman & Wakefield Ltd common stock, representing 11.8% of the class. The filing shows BlackRock has sole voting power over 27,468,795 shares and sole dispositive power over 27,719,552 shares. The statement notes iShares Core S&P Small-Cap ETF holds more than 5% of the same class. The filing is signed by Spencer Fleming on 06/04/2026.
Cushman & Wakefield Ltd. is reshaping its debt profile through a planned amendment to its senior secured term loan and a conditional partial bond redemption. The company expects to amend its Credit Agreement so that approximately $848 million of existing term loans (the 2026-1 Term Loans) are repriced, have their maturity extended to a date seven years from the amendment’s effective date, and are upsized by about $353 million. These loans are expected to bear interest at Term SOFR plus 2.25% or a Base Rate plus 1.25%. Around $840 million of other term loans (the 2025-3 Term Loans) are expected to be unchanged. Separately, the U.S. Borrower has elected to redeem $350 million of its $550 million 6.750% Senior Secured Notes due May 2028 at 100% of principal plus accrued interest, with completion targeted for June 15, 2026. This partial redemption is conditioned on completing refinancing transactions that generate sufficient net proceeds, although the borrower may waive this condition.
Cushman & Wakefield Ltd. director Michelle Felman reported bona fide gifts of a total of 34,026 Common Shares on June 1, 2026. The transactions reflect gift transfers rather than any open-market buying or selling.
One 17,013-share gift involved shares previously held directly, leaving her with no direct holdings. Another 17,013-share gift involved shares associated with family trusts. Following these transactions, she reports 44,857 Common Shares held indirectly through family trusts, over which she has investment control, for the sole benefit of certain immediate family members.
Cushman & Wakefield Ltd. director Michelle Felman reported equity compensation activity involving restricted stock units (RSUs). On May 15, 2026, she exercised previously awarded RSUs, converting 17,013 RSUs into the same number of common shares without paying any cash consideration.
On May 14, 2026, she received a new grant of 14,041 RSUs that will vest and settle on May 14, 2027, subject to continued board service. Following these transactions, she holds 17,013 common shares directly, 27,844 common shares indirectly through family trusts over which she has investment control, and 14,041 RSUs outstanding.
Cushman & Wakefield Ltd. director Billie Ida Williamson reported routine equity compensation movements involving restricted stock units (RSUs) and common shares. On May 15, 2026, previously awarded RSUs converted into 17,013 common shares without any cash payment, under the company’s omnibus non-employee director incentive plan.
Following this conversion, Williamson held 106,005 common shares directly. A day earlier, on May 14, 2026, Williamson received a new grant of 14,041 RSUs that will vest and settle into an equal number of common shares on May 14, 2027, if board service continues through that date. The Form 4 shows no open-market purchases or sales, only compensation-related grants and RSU conversions.
PLAVIN STEPHEN D reported acquisition or exercise transactions in this Form 4 filing.
Cushman & Wakefield Ltd. director Stephen D. Plavin reported a compensation-related grant of 21,841 restricted stock units on May 14, 2026. Each RSU represents one common share and requires no purchase price.
The RSUs vest and settle on May 14, 2027, generally contingent on his continued board service through that date. Following this award, he holds 21,841 RSUs directly, each convertible into an equal number of common shares.
Cushman & Wakefield Ltd. reported that director Susan Daimler received a grant of 14,041 restricted stock units (RSUs). These RSUs were granted on May 14, 2026 under the company’s 2026 Omnibus Share and Cash Incentive Plan as equity-based board compensation.
The RSUs convert into an equal number of common shares without any cash payment, but they vest and settle on May 14, 2027, generally requiring her continued board service through that date. After this grant, she is reported as holding 14,041 RSUs directly, with no open-market purchases or sales disclosed in this filing.
Cushman & Wakefield Ltd. reported that director Timothy H. Wennes received a grant of 14,041 restricted stock units (RSUs). These RSUs were awarded under the Cushman & Wakefield Ltd. 2026 Omnibus Share and Cash Incentive Plan and will convert into an equal number of common shares without any cash payment.
The RSUs were granted on May 14, 2026 and are scheduled to vest and settle on May 14, 2027, generally conditional on his continued board service through that date. Following this grant, Wennes holds 14,041 RSUs directly.